Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CVX | XOM |
|---|---|---|
| Price | $205.78 | $161.49 |
| Change today | ▲ 0.13% | ▲ 0.16% |
| Market cap | $406.57B | $664.03B |
| Return, 3 months | +21.1% | +18.7% |
| Return, year to date | +38.8% | +36.9% |
| Return, 1 year | +34.4% | +45.1% |
| P/E (TTM) | 19.8 | 20.8 |
| P/B | 2.1 | 2.6 |
| P/E percentile vs own 5y | 76th | 90th |
| Dividend yield | 3.39% | 2.53% |
| Revenue growth (YoY, latest qtr) | +51.4% | +44.1% |
| Net profit growth (YoY) | +385.6% | +102.4% |
| Gross margin | 32.4% | 20.6% |
| Operating margin | 12.4% | 10.7% |
| Net margin | 9.9% | 9.1% |
| Return on equity | 12.2% | 12.6% |
| Analyst target vs. price | +7.1% | +5.4% |
| Analyst buy share | 81% | 50% |
| RSI (14) | 50 | 51 |
| 30-day volatility | 21.9% | 25.7% |
| Max drawdown, 1 year | -20.8% | -20.1% |
| Trend read | Leaning bullish | Leaning bullish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.